Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small Molecule Drugs in Inflammatory Bowel Diseases
Inès Ben Ghezala, Maëva Charkaoui, Christophe Michiels, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 637-637
Open Access | Times Cited: 24

Showing 24 citing articles:

Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease
Elizabeth Spencer, Suzannah Bergstein, Michael T. Dolinger, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 11, pp. 2057-2063
Closed Access | Times Cited: 18
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice
Rupa Banerjee, Vishal Sharma, Rajendra Patel, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 22-35
Closed Access | Times Cited: 7
Upadacitinib in Crohn’s disease
Axel Dignaß, Philip Esters, Cathrin Flauaus
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 359-370
Closed Access | Times Cited: 7
Crohn's disease and clinical management today: How it does?
Ronaldo Teixeira da Silva Júnior, Jonathan Santos Apolonio, Jéssica Oliveira de Souza Nascimento, et al.
World Journal of Methodology (2023) Vol. 13, Iss. 5, pp. 399-413
Open Access | Times Cited: 10
Decade-Long Trends in Hospitalization, Outcomes, and Emergency Department Visits for Inflammatory Bowel Diseases in the United States, 2010 to 2020
Queeneth C Edwards, Oluwatoyin Ayo-Farai, Fidelis E Uwumiro, et al.
Cureus (2025)
Open Access
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
Raffaele Pellegrino, Giuseppe Imperio, Ilaria De Costanzo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 308-308
Open Access
Cyclodextrin Nanoparticles and Injectable Polymer-Nanoparticle Hydrogels for Macrophage-Targeted Delivery of Small-Molecule Drugs
Shreya S. Soni, Christopher B. Rodell
Methods in molecular biology (2025), pp. 117-131
Closed Access
Comparative efficacy of pharmacological interventions in ulcerative colitis: A Network Meta Analysis
Atta Ullah Khan, Maria Ali, Muhammad Aamir Wahab
Research Square (Research Square) (2025)
Closed Access
Comparative efficacy of pharmacologic interventions in ulcerative colitis: a network meta analysis
Atta Ullah Khan, Maria Ali, Muhammad Aamir Wahab
Inflammopharmacology (2025)
Open Access
A Comprehensive Review of Small Molecules, Targets, and Pathways in Ulcerative Colitis Treatment
Xiaoxuan Cai, Yi-Han Huang, Yang-Chi-Dung Lin, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117645-117645
Closed Access
Dual biological therapy and small molecules in pediatric inflammatory bowel disease
Francesca Penagini, Luisa Lonoce, Luisa Abbattista, et al.
Pharmacological Research (2023) Vol. 196, pp. 106935-106935
Open Access | Times Cited: 9
Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review
Niloufar Monfared, Matthew Gold, Isabel Carbery, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 34-34
Open Access | Times Cited: 8
An exosomal approach for oral delivery of resveratrol: Implications for inflammatory bowel disease treatment in rat model
Shaghayegh Kazemi Esfahani, Sadegh Dehghani, Hossein Hosseinzadeh, et al.
Life Sciences (2024) Vol. 346, pp. 122638-122638
Closed Access | Times Cited: 3
Saposhnikovia divaricata root and its major components ameliorate inflammation and altered gut microbial diversity and compositions in dextran sodium sulfate-induced colitis
Saruul Erdenebileg, Yang‐Ju Son, Myungsuk Kim, et al.
Integrative Medicine Research (2023) Vol. 12, Iss. 4, pp. 100998-100998
Open Access | Times Cited: 8
Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling
Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e34066-e34066
Open Access | Times Cited: 2
Medical management of pediatric inflammatory bowel disease
Brad Pasternak
Seminars in Pediatric Surgery (2024) Vol. 33, Iss. 2, pp. 151398-151398
Closed Access | Times Cited: 1
Selecting first-line advanced therapy for ulcerative colitis: A clinical application of personalized medicine
Mariam S Mukhtar, Mahmoud Mosli
Saudi Journal of Gastroenterology (2024) Vol. 30, Iss. 3, pp. 126-137
Open Access | Times Cited: 1
JAK inhibitors in crohn’s disease: ready to go?
Cecilia Dell’Avalle, Ferdinando D’Amico, Roberto Gabbiadini, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 2, pp. 145-161
Closed Access | Times Cited: 3
Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis
Daniel Tassone, Chamara Basnayake, Emily K. Wright, et al.
Internal Medicine Journal (2023) Vol. 54, Iss. 3, pp. 446-454
Open Access | Times Cited: 1
Bibliometric Analysis of Research Trends in Ulcerative Colitis Treatments: 2003-2023
Chaofan Chen, Zhiyun Zhang, Pengfei Yuan, et al.
(2024)
Closed Access
O USO DO VEDOLIZUMBABE NO TRATAMENTO DA DOENÇA DE CRONH: UMA REVISÃO INTEGRATIVA
Sophia Ponciano de Souza, Paulo Gabriel Marques Leite, Ana Júlia Oliveira Silva, et al.
Revista Foco (2024) Vol. 17, Iss. 7, pp. e5563-e5563
Open Access
Gut Microbiome Influence on Human Epigenetics, Health, and Disease
Martin Watson, Mark van der Giezen, Kjetil Søreide
Elsevier eBooks (2022), pp. 669-686
Closed Access | Times Cited: 2
NEW MEDICAL APPROACHES IN CROHN’S DISEASE TREATMENT
Miruna-Ioana MIRON
Annals of the Academy of Romanian Scientists Series of Medicine (2023) Vol. 4, Iss. 1, pp. 29-37
Open Access
A comprehensive review and update on acute severe lower gastrointestinal bleeding in Crohn’s disease: a management algorithm
Tong Tu, Mengqi Chen, Zhirong Zeng, et al.
Gastroenterology report (2023) Vol. 12
Open Access
Page 1

Scroll to top